• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, November 22, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Technology

EV2 Technologies Secures NIH Award to Advance Biodegradable Stent Alternative

by
November 20, 2026
in Technology
Reading Time: 3 mins read
0
EV2 Technologies Secures NIH Award to Advance Biodegradable Stent Alternative

EV2 Technologies Secures NIH Award to Advance Biodegradable Stent Alternative

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

EV2 Technologies, a startup spun out of the University of Pittsburgh, has been awarded a two-year, $2.1 million Small Business Innovation Research Direct-to-Phase II grant from the National Institutes of Health National Heart, Lung, and Blood Institute. The non-dilutive award directly supports the ongoing development and testing of Biocarpet, an endovascular device designed as a fully biodegradable sheet that unfurls inside diseased blood vessels to treat peripheral artery disease. The condition currently affects more than 12 million people across the United States and approximately 200 million individuals worldwide, driving demand for interventions capable of relieving severe arterial blockages.

While stents are commonly used to treat the disease, these devices are not compatible with small or winding arteries and often fail after they are implanted, particularly in vessels that cross joints. According to Jonathan Vande Geest, an EV2 co-founder and professor of bioengineering at Pitt’s Swanson School of Engineering, blood vessels are not just straight tubes and can become a very complex biomechanical environment as people age. Biocarpet was invented to provide a solution that conforms to this complicated vascular anatomy and reduces the likelihood of restenosis.

The underlying biomedical technology represents the culmination of multiple years of collaborative academic research conducted at the University of Pittsburgh. Alongside Vande Geest, the founding team includes chief executive officer and principal investigator Ali Behrangzade, who completed his bioengineering doctorate at Pitt in 2022, bioengineering distinguished professor William R. Wagner, and John Pacella, an associate professor at Pitt’s School of Medicine who also practices as an interventional cardiologist at the University of Pittsburgh Medical Center.

Over the upcoming two-year grant period, EV2 Technologies will deploy the federal funding across several interrelated preclinical development tracks. The team will refine its manufacturing process to lay the foundation for scalability. In tandem, engineering teams will redesign the specialized thermal balloon catheter required to deliver and deploy the unfurling sheet within targeted vessels. The team also plans to develop an accompanying control console engineered for broad compatibility across standardized clinical catheterization laboratories.

Alongside those engineering updates, the company will run a wide range of benchtop testing on the improved prototypes. The benchtop testing will be followed by a six-month study to assess the device's safety and efficacy in an animal model.

The trajectory leading to the Direct-to-Phase II award was established through sequential translational support mechanisms across regional and federal innovation ecosystems. Initial proof-of-concept work began in 2019 when Pitt’s Center for Medical Innovation provided early funding for benchtop feasibility demonstrations. That foundational research positioned the concept to secure awards in institutional venture programs, including the Wells Student HealthTech Challenge, the Randall Family Big Idea Center Pitch Competition, and the Pitt Innovation Challenge, which collectively provided the momentum necessary for continued translational execution.

Translational acceleration continued when Behrangzade joined the university faculty full-time in 2022, enabling dedicated experimental campaigns that generated critical quantitative datasets. In 2023, Vande Geest secured an NIH Catalyze grant with Behrangzade serving as co-investigator and project lead. The Catalyze funding allowed the team to bypass the traditional Phase I SBIR process, and the data it produced ultimately led to the successful application for the Direct-to-Phase II SBIR award now funding the company’s current work.

The award also marks a turning point for EV2, providing the resources to formally license the underlying technology from the University for the first time. Looking forward, the company plans to maintain a balanced capital strategy combining non-dilutive public research grants with private venture capital investment. Vande Geest noted that without support from programs including the Office for Innovation and Entrepreneurship, CMI, the McGowan Institute for Regenerative Medicine, LifeX, and the NHLBI, the technology would not be where it is today.

Subject of Research: Biodegradable endovascular sheet development for peripheral artery disease treatment

Article Title: A flexible fix for rigid stents

Article References: A flexible fix for rigid stents. Original publication (Bibliographic details unavailable.)

Image Credits: AI Generated

DOI: Not provided

Keywords: EV2 Technologies, Biocarpet, peripheral artery disease, biodegradable sheet, NIH NHLBI, SBIR Direct-to-Phase II, University of Pittsburgh, Swanson School of Engineering, Jonathan Vande Geest, Ali Behrangzade, restenosis, thermal balloon catheter, endovascular device, preclinical animal study, vascular biomechanics, Center for Medical Innovation

News Source: Denise Maddox. (November 20, 2026). EV2 Technologies Secures NIH Award to Advance Biodegradable Stent Alternative. Scienmag.

Tags: Ali BehrangzadeBiocarpetbiodegradable sheetCenter for Medical Innovationendovascular deviceEV2 TechnologiesJonathan Vande GeestNIH NHLBIperipheral artery disease.preclinical animal studyrestenosisSBIR Direct-to-Phase IISwanson School of Engineeringthermal balloon catheterUniversity of Pittsburghvascular biomechanics
Share12Tweet7Share2ShareShareShare1

Related Posts

Computational Design Models Metal-Free Bloch Surface Wave Optical Fiber Sensor

Computational Design Models Metal-Free Bloch Surface Wave Optical Fiber Sensor

November 22, 2026
Open-Source Framework ESFEX Matches Benchmark Consensus Across Ten Power Grid Systems

Open-Source Framework ESFEX Matches Benchmark Consensus Across Ten Power Grid Systems

November 22, 2026

Open Source QGIS Plugin Automates Multi Method Spatial Interpolation for Agriculture

November 22, 2026

Harmony Framework Unifies Modeling and Stability Analysis for Hybrid Power Grids

November 22, 2026

POPULAR NEWS

  • Open-Source Framework ESFEX Matches Benchmark Consensus Across Ten Power Grid Systems

    Open-Source Framework ESFEX Matches Benchmark Consensus Across Ten Power Grid Systems

    29 shares
    Share 12 Tweet 7
  • Endothelial FBXW7 Degrades NOTCH1 to Silence SEMA3G and Curb Liver Fibrosis

    29 shares
    Share 12 Tweet 7
  • Open Source QGIS Plugin Automates Multi Method Spatial Interpolation for Agriculture

    29 shares
    Share 12 Tweet 7
  • Herbal Nanovesicles Suppress Colorectal Tumors and Boost Immunotherapy in Mouse Models

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Computational Design Models Metal-Free Bloch Surface Wave Optical Fiber Sensor

Cultivation Environment Reshapes Aroma and Nutrient Chemistry in Sarcomyxa edulis Mushrooms

Open-Source Framework ESFEX Matches Benchmark Consensus Across Ten Power Grid Systems

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 89 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.